Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.
Cervical Disk Pathology in Patients With Multiple Sclerosis: Two Case Reports.
Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial.
The role of endogenous antiradical protective system in multiple sclerosis.
Incidence of Multiple Sclerosis in the General Population in the Netherlands, 1996-2008.
Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis.
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
Multiple Sclerosis Disease Progression and Paradichlorobenzene: A Tale of Mothballs and Toilet Cleaner.
Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.
Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.
Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease
Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source.
Biomarkers in Multiple Sclerosis: An Up-to-Date Overview.
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
A palliative care hotline for multiple sclerosis: A pilot feasibility study.
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency.
CCR2+CCR5+ T Cells Producing Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis.
Anatomical Brain Networks on the Prediction of Abnormal Brain States.
Pages
« first
‹ previous
…
228
229
230
231
232
233
234
235
236
…
next ›
last »